Phase 4
Completed N=80
Effect of Intraoperative Dexamethasone on Post-op Dry Eye
Dry Eye Syndromes
Source: ClinicalTrials.gov NCT04184999 ↗
Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Jan 2021
Primary outcomePrimary: Evaluation of Intraoperative Use of Dexycu on Tear Film Osmolarity at 3 Weeks Postoperatively — 311.15; 316.3 mOsmol/L — p=<.01
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
To compare the signs and symptoms of dry eye after cataract surgery between subjects randomized to receive intraoperative dexamethasone in addition to the use of a standard topical post-op treatment regimen.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Evaluation of Intraoperative Use of Dexycu on Tear Film Osmolarity at 3 Weeks Postoperatively |
311.15; 316.3 | <.01 sig |
Eligibility Criteria
Inclusion Criteria
- undergoing bilateral cataract surgery
Exclusion Criteria
- central corneal staining with fluorescein and/or a tear film osmolarity of greater than 340 in either eye
Data sourced from ClinicalTrials.gov (NCT04184999). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.